Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation, brain-computer interface (BCI) ...

Mobia Medical is pursuing an IPO to fund commercialization of its FDA-approved Vivistim neurostimulation device for stroke ...

The company's FDA-cleared wearable uses personalized nerve stimulation to treat essential tremor and Parkinson's disease.

Lenire will be exclusively available through hearing care clinics with expertise in tinnitus in Ontario, British Columbia, Alberta, Manitoba, and Québec. Lenire will be available ...

NeurAxis, Inc. ('NeurAxis” or the 'Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and ...

Nearly half of all Canadian adults have experienced tinnitus in their lifetime and a new at-home tinnitus treatment device offers chronic sufferers hope. Lenire will be exclusively available through ...

Neuvotion announced today that it plans to launch its FDA-cleared NeuStim neurostimulation. technology later this year.

Sidra Medicine, has successfully performed a sacral neuromodulation implantation procedure on an eight year old child with ...

Bioness Medical has acquired the full PoNS system product line, including the noninvasive device used for better walking and ...

(NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the ...